US2021379265A1PendingUtilityA1

Method and system for controlled hyperthermia

Assignee: VERTHERMIA ACQUISITION INCPriority: Apr 30, 2019Filed: Jun 24, 2021Published: Dec 9, 2021
Est. expiryApr 30, 2039(~12.8 yrs left)· nominal 20-yr term from priority
A61L 2103/09A61L 2/04B01D 15/00A61M 2205/3606B01J 20/282B01J 20/28052A61M 1/369B01D 2311/2626A61M 1/1656A61M 1/3666B01D 15/08A61M 5/1413B01J 20/103A61L 2/26A61M 2230/20A61M 2230/50A61M 2205/366A61L 2202/14B01J 20/10B01J 20/20A61M 1/1696A61M 1/1629A61F 2007/126A61M 1/267A61M 1/3679A61M 1/1654A61M 2205/3334B01D 2311/2649A61M 2202/0423Y02C20/40A61M 2230/208B01J 2220/58A61L 2202/11A61L 2/0023A61L 2103/05
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and for treatment of cancer and other diseases including complications from late stage viral infections by inducing hyperthermia in a patient relying on withdrawing blood from the patient and returning the withdrawn blood to the patient to establish an extracorporeal flow circuit. Blood is heated by passing through the extracorporeal circuit at a controlled rate until a target body core temperature in is achieved. Usually, the blood will be subjected to a continuously re-circulating dialysis to balance electrolytes. Additionally, the blood will be subjected to a continuously recirculating regeneration through a carbon sorbent column where toxins and contaminants are removed. The blood temperature is maintained at the target blood temperature for a treatment period, and the blood is cooled after the treatment period has been completed. The method can also be effective in treating rheumatoid arthritis, scleroderma, hepatitis, sepsis, the Epstein-Barr virus, and patients with life threatening complications from other viruses, including the COVID-19 virus. A method for removing viruses from the blood supply in an external circuit is also presented.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating blood stored in the blood supply by establishing a stand-alone external circuit wherein blood is heated to between 40° C. and 49° C. for between 10 and 45 minutes in order to eliminate any viruses that may be contained in the blood. 
     
     
         2 . A method as in  claim 1  where the blood is heated to between 45° C. and 47° C. 
     
     
         3 . A method as in  claim 1  where the treatment period is between 15 and 35 minutes. 
     
     
         4 . A method as in  claim 1  where the standalone external circuit comprises:
 a. a modular cooler heater; 
 b. a pump/agitator to ensure the blood is moving through the circuit; and 
 c. a blood chemistry analyzer to ensure the blood chemistry remains within acceptable limits. 
 
     
     
         5 . A method as in  claim 1  where the blood is heated and cooled slowly. 
     
     
         6 . A method as in  claim 1  where all normal precautions during treatment and handling of blood are exercised in order to ensure that the blood is not damaged. 
     
     
         7 . A method as in  claim 1  where the blood is returned to its normal storage temperature of 6° C. after treatment.

Join the waitlist — get patent alerts

Track US2021379265A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.